Literature DB >> 18945502

Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts.

Tzu-Hurng Cheng1, Jia-Wei Lin, Hung-Hsin Chao, Yen-Ling Chen, Cheng-Hsien Chen, Paul Chan, Ju-Chi Liu.   

Abstract

BACKGROUND: The association between hyperuricemia and cardiovascular diseases has long been recognized. Elevated levels of uric acid may have a causal role in hypertension and cardiovascular diseases. However, the direct effect of uric acid on cardiac cells remains unclear. Therefore, this study was aimed to examine the effect of uric acid in rat cardiac fibroblasts and to identify the putative underlying signaling pathways.
METHODS: Cultured rat cardiac fibroblasts were stimulated with uric acid; cell proliferation and endothelin-1 (ET-1) gene expression were examined. The effect of uric acid on NADPH oxidase activity, reactive oxygen species (ROS) formation, and extracellular signal-regulated kinases (ERK) phosphorylation were tested to elucidate the intracellular mechanism of uric acid in ET-1 gene expression.
RESULTS: Uric acid-increased cell proliferation and ET-1 gene expression. Uric acid also increased NADPH oxidase activity, ROS formation, ERK phosphorylation, and activator protein-1 (AP-1)-mediated reporter activity. Antioxidants suppressed uric acid-induced ET-1 gene expression, and ERK phosphorylation, and AP-1 reporter activities. Mutational analysis of the ET-1 gene promoter showed that AP-1 binding site was an important cis-element in uric acid-induced ET-1 gene expression.
CONCLUSIONS: These results suggest that uric acid-induced ET-1 gene expression, partially by the activation of ERK pathway via ROS generation in cardiac fibroblasts. Copyright 2008 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945502     DOI: 10.1016/j.ijcard.2008.09.004

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  22 in total

1.  Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis.

Authors:  Da P Chen; Chun K Wong; Lai S Tam; Edmund K Li; Christopher W K Lam
Journal:  Cell Mol Immunol       Date:  2011-09-26       Impact factor: 11.530

2.  Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake.

Authors:  Carlos A Roncal-Jimenez; Miguel A Lanaspa; Christopher J Rivard; Takahiko Nakagawa; L Gabriela Sanchez-Lozada; Diana Jalal; Ana Andres-Hernando; Katsuyuki Tanabe; Magdalena Madero; Nanxing Li; Christina Cicerchi; Kim Mc Fann; Yuri Y Sautin; Richard J Johnson
Journal:  Metabolism       Date:  2011-04-12       Impact factor: 8.694

Review 3.  Uric Acid and Cardiovascular Disease: An Update.

Authors:  Maria Lorenza Muiesan; Claudia Agabiti-Rosei; Anna Paini; Massimo Salvetti
Journal:  Eur Cardiol       Date:  2016-08

4.  Interaction between uric acid and HMGB1 translocation and release from endothelial cells.

Authors:  May M Rabadi; Mei-Chuan Kuo; Tammer Ghaly; Seham M Rabadi; Mia Weber; Michael S Goligorsky; Brian B Ratliff
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-21

Review 5.  Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?

Authors:  Ankoor Shah; Robert T Keenan
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

Review 6.  Endothelin, hypertension and chronic kidney disease: new insights.

Authors:  Donald E Kohan
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

7.  Combination of captopril and allopurinol retards fructose-induced metabolic syndrome.

Authors:  Carlos A Roncal; Sirirat Reungjui; Laura Gabriela Sánchez-Lozada; Wei Mu; Yuri Y Sautin; Takahiko Nakagawa; Richard J Johnson
Journal:  Am J Nephrol       Date:  2009-08-21       Impact factor: 3.754

8.  Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study.

Authors:  O James Ekundayo; Louis J Dell'Italia; Paul W Sanders; Donna Arnett; Inmaculada Aban; Thomas E Love; Gerasimos Filippatos; Stefan D Anker; Donald M Lloyd-Jones; George Bakris; Marjan Mujib; Ali Ahmed
Journal:  Int J Cardiol       Date:  2009-02-06       Impact factor: 4.164

9.  Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?

Authors:  Sergey I Zharikov; Erik R Swenson; Miguel Lanaspa; Edward R Block; Jawaharlal M Patel; Richard J Johnson
Journal:  Med Hypotheses       Date:  2010-01-12       Impact factor: 1.538

Review 10.  Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?

Authors:  Angelo L Gaffo; N Lawrence Edwards; Kenneth G Saag
Journal:  Arthritis Res Ther       Date:  2009-08-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.